PAT Frontiers Forum
A focused forum for biopharma leaders navigating the future of manufacturing, analytics, and process control.
Process Analytical Technology (PAT) is being rewritten on three conventional fronts at once: autonomous manufacturing, AI-driven process decisions, and emerging modalities that don't fit the monoclonal antibody playbook.
Waters is bringing senior leaders from across biopharma, CDMOs, and biosimilar organizations together for a day built around exactly these shifts: what's coming next and how leading organizations are preparing for it.
Why It's Worth Your Day
- Hear candid lessons from organizations redefining what PAT can deliver.
- Leave with a clearer view of where lights-out manufacturing, AI-driven process control, and PAT for new modalities are realistically headed over the next two to three years.
- Build relationships with the leaders shaping PAT strategy across the industry, and cultivate connections for potential future collaboration.
What We're Digging Into
- Lights-Out Manufacturing and Labs: what it takes to reduce human intervention, and where today's technology still falls short.
- Data, Digital and AI Integration: separating real AI/ML impact on process control from the hype.
- PAT for New Modalities: practical approaches for peptides, ADCs, liposomes, and viral vectors.
- PAT for Synthetic Biology: where cell therapy and synthetic biology are pushing PAT into new territory.
Agenda Coming Soon
When?
Where?
Immerse Cambridge,
For more information, please contact:
Jen Halsey Jennifer_halsey@waters.com or Ranjeet Patil ranjeet_patil@waters.com